Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,331 public trials 1,293 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Recruiting

A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer

NCT06764316

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Dothan Dothan, Alabama, United States
  • Duarte Duarte, California, United States
  • Edegem Edegem, Antwerp, Belgium
  • Leuven Leuven, Flemish Brabant, Belgium
View all 20 locations
View Trial Details
Recruiting

STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma

NCT06880523

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
  • BCCA - Vancouver Vancouver, British Columbia, Canada
  • Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
  • Kingston Health Sciences Centre Kingston, Ontario, Canada
View Trial Details
Recruiting

Role of Nutritional Intervention for the Treatment of Sarcopenia in Cirrhotic Patients With Refractory Ascites Candidate to Transjugular Intrahepatic Portosystemic Shunt Placement and Identification of Prognostic Factors Related to Clinical Outcome

NCT06814626

Conditions
Ascites, Atrophy, Digestive System Diseases, +14 more
Locations
  • IRCCS ISMETT - Istituto Mediterraneo per i Trapianti e le Terapie ad Alta Specializzazione Palermo, Italy
  • University Clinic for Visceral Surgery and Medicine, Inselspital Bern, Switzerland
View Trial Details
Recruiting

Functional Assessment in Liver Transplantation

NCT03228290

Conditions
Digestive System Diseases, End Stage Liver Disease, Fibrosis, +6 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Loma Linda University Loma Linda, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Northwestern University Chicago, Illinois, United States
View Trial Details
Recruiting

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

NCT07555483

Conditions
Alpha 1 Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • GC2501 Study Site 106 Birmingham, Alabama, United States
  • GC2501 Study Site 102 Phoenix, Arizona, United States
  • GC2501 Study Site 107 Scottsdale, Arizona, United States
  • GC2501 Study Site 100 Los Angelas, California, United States
View all 22 locations
View Trial Details

Related conditions